News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
692,530 Results
Type
Article (39382)
Company Profile (247)
Press Release (652901)
Section
Business (204027)
Career Advice (2005)
Deals (35405)
Drug Delivery (93)
Drug Development (80940)
Employer Resources (169)
FDA (16133)
Job Trends (14828)
News (344876)
Policy (32473)
Tag
Academia (2535)
Alliances (49313)
Alzheimer's disease (1314)
Approvals (16117)
Artificial intelligence (199)
Bankruptcy (357)
Best Places to Work (11637)
Biotechnology (175)
Breast cancer (225)
Cancer (1710)
Cardiovascular disease (128)
Career advice (1669)
CAR-T (121)
Cell therapy (353)
Clinical research (65243)
Collaboration (659)
Compensation (370)
COVID-19 (2563)
C-suite (160)
Data (1629)
Diabetes (211)
Diagnostics (6282)
Earnings (85436)
Employer resources (146)
Events (110862)
Executive appointments (564)
FDA (17034)
Funding (602)
Gene therapy (245)
GLP-1 (648)
Government (4357)
Healthcare (18768)
Infectious disease (2674)
Interviews (310)
IPO (16461)
Job creations (3627)
Job search strategy (1420)
Layoffs (437)
Legal (7885)
Lung cancer (255)
Manufacturing (235)
Medical device (13261)
Medtech (13266)
Mergers & acquisitions (19319)
Metabolic disorders (548)
Neuroscience (1715)
NextGen: Class of 2025 (6509)
Non-profit (4475)
Northern California (2090)
Obesity (306)
Opinion (193)
Patents (162)
People (56829)
Phase I (20315)
Phase II (28744)
Phase III (21397)
Pipeline (711)
Postmarket research (2562)
Preclinical (8575)
Radiopharmaceuticals (241)
Rare diseases (321)
Real estate (5897)
Regulatory (21917)
Research institute (2311)
Resumes & cover letters (349)
Southern California (1791)
Startups (3567)
United States (18436)
Vaccines (611)
Weight loss (208)
Date
Today (11)
Last 7 days (593)
Last 30 days (2480)
Last 365 days (34386)
2025 (4427)
2024 (35218)
2023 (40076)
2022 (51174)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (716)
Arizona (211)
Asia (37505)
Australia (6132)
California (4761)
Canada (1715)
China (392)
Colorado (217)
Connecticut (230)
Europe (80384)
Florida (688)
Georgia (165)
Illinois (455)
Indiana (259)
Japan (121)
Maryland (739)
Massachusetts (3602)
Michigan (198)
Minnesota (334)
New Jersey (1347)
New York (1359)
North Carolina (833)
Northern California (2090)
Ohio (173)
Pennsylvania (1098)
South America (1093)
Southern California (1791)
Texas (701)
Utah (143)
Washington State (467)
692,530 Results for "alumis inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
Concentra Offers to Buy Acelyrin, Endangering Proposed Merger With Alumis
Acelyrin earlier this month agreed to an all-stock merger with fellow immune player Alumis, with their combined cash tiding the combined company over until 2027.
February 21, 2025
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Nasdaq Neophytes Acelyrin, Alumis Merge to Tackle Immune-Mediated Diseases
Alumis held its initial public offering in June last year, while Acelyrin debuted on the Nasdaq in mid-2023.
February 7, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Alumis Strengthens Leadership Team with Key Appointments
January 29, 2025
·
7 min read
Press Releases
Alumis to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference
February 11, 2025
·
2 min read
Deals
Alumis Announces Pricing of Initial Public Offering - June 28, 2024
Alumis Inc. announced the pricing of its initial public offering of 13,125,000 shares of common stock at an initial public offering price of $16.00 per share.
June 28, 2024
·
6 min read
Press Releases
Alumis and ACELYRIN to Merge Creating a Late-Stage Clinical Biopharma Company Dedicated to Innovating, Developing and Commercializing Transformative Therapies for Immune-mediated Diseases
February 7, 2025
·
19 min read
Press Releases
Alumis to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference
November 4, 2024
·
2 min read
Press Releases
Alumis Announces Positive Phase 1 Data for CNS Penetrant TYK2 Inhibitor, A-005
December 19, 2024
·
7 min read
Biotech Bay
Alumis to Participate in the 2024 Leerink Partners Global Biopharma Conference
Alumis Inc. today announced that Company management will host investor meetings at the 2024 Leerink Partners Global Biopharma Conference on March 12, 2024, in Miami, Florida.
March 11, 2024
·
1 min read
Press Releases
Alumis Reports Third Quarter 2024 Financial Results and Highlights Recent Achievements
November 14, 2024
·
10 min read
1 of 69,253
Next
